Joerg Heckenkamp
University of Cologne
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Joerg Heckenkamp.
Journal of Endovascular Therapy | 2008
Thomas Luebke; Michael Gawenda; Joerg Heckenkamp; Jan Brunkwall
Purpose: To compare radiofrequency obliteration (RFO) and conventional surgery with respect to postoperative complications, effectiveness of treatment, and quality of life (QoL). Methods: Several healthcare databases were interrogated to identify all studies published between 1994 and 2007 comparing RFO in primary varicosis to conventional therapy with vein ligation and stripping. Of 65 articles identified, 8 studies representing 428 patients [224 (52%) endovenous RFO and 204 (48%) stripping] were eligible for the meta-analysis. Adverse events, effectiveness, and QoL outcomes were assessed at several time points up to 2 years. Results: There were significant reductions in tenderness and ecchymosis at 1 week and significantly fewer hematomas at 72 hours, 1 week, and 3 weeks associated with RFO. There was no significant difference between the RFO and surgery in immediate or complete great saphenous vein (GSV) occlusion, incomplete GSV closure, freedom from reflux, recurrent varicose veins, recanalization, or neovascularization. QoL results significantly favoring RFO over surgery included return to normal activity and return to work. Conclusion: It seems that RFO benefits most patients in the short term, but rates of recanalization, re-treatment, occlusion, and reflux may alter with longer follow-up. The lack of such data demonstrates the need for further randomized clinical trials of RFO versus conventional surgery.
Annals of Vascular Surgery | 2008
M. Aleksic; Thomas Luebke; Joerg Heckenkamp; Michael Gawenda; Viktor Reichert; Jan Brunkwall
In carotid surgery, it could be useful to know which patient will tolerate carotid cross-clamping in order to minimize the risks of perioperative strokes. In this clinical study, an artificial neuronal network (ANN) was applied and compared with conventional statistical methods to assess the value of various parameters to predict shunt necessity. Eight hundred and fifty patients undergoing carotid endarterectomy for a high-grade internal carotid artery stenosis under local anesthesia were analyzed regarding shunt necessity using a standard feed-forward, backpropagation ANN (NeuroSolutions); NeuroDimensions, Gainesville, FL) with three layers (one input layer, one hidden layer, one output layer). Among the input neurons, preoperative clinical (n = 9) and intraoperative hemodynamic (n = 3) parameters were examined separately. The accuracy of prediction was compared to the results of a regression analysis using the same variables. In 173 patients (20%) a shunt was used because hemispheric deficits or unconsciousness occurred during cross-clamping. With the ANN, not needing a shunt was predicted by preoperative and intraoperative parameters with an accuracy of 96% and 91%, respectively, where the regression analysis showed an accuracy of 98% and 96%, respectively. Those patients who needed a shunt were identified by preoperative parameters in 9% and by intraoperative parameters in 56% when the ANN was used. Regression analysis predicted shunt use correctly in 10% using preoperative parameters and 41% using intraoperative parameters. Intraoperative hemodynamic parameters are more suitable than preoperative parameters to indicate shunt necessity where the application of an ANN provides slightly better results compared to regression analysis. However, the overall accuracy is too low to renounce perioperative neuromonitoring methods like local anesthesia.
Scandinavian Cardiovascular Journal | 1997
Joerg Heckenkamp; Hanns-J. Helling; K. E. Rehm
Candida costochondritis is a rare disease of complex aetiology. Pathogenetic factors range from postoperative and posttraumatic complications to haematogenous dissemination in intravenous drug addicts. In addition to clinical examination, possible diagnostic procedures include scintiscan and magnetic resonance imaging. The treatment of choice is extensive debridement and resection of the structures affected by the inflammatory process. The long-term prognosis is good.
Interactive Cardiovascular and Thoracic Surgery | 2012
Joerg Heckenkamp; Thomas Luebke; Thorsten Theis; Lukas Schumacher; Michael Gawenda; Roland Thul; Jochen W.U. Fries; Jan Brunkwall
The hypothesis driving this study was that photodynamic therapy (PDT) may limit abdominal aortic aneurysm growth due to matrix changes. The aortas of 12 rats were incubated with elastase using a newly modified experimental aneurysm model (3.5 mg/ml). Rats were allocated to an elastase-only group (n = 6) to study the elastase-induced aneurysm growth and an elastase ± PDT group to evaluate if PDT limited aneurysm growth (n = 6). PDT was performed with the photosensitizer methylene blue, and thermoneutral laser light (660 nm) was applied (120 J/cm(2), 100 mW/cm(2)) using a diode laser. Four untreated rats served as controls. The arteries were analysed after 4 weeks based on histology, immunohistochemistry and morphometry. This modified rat elastase model led to reproducible aneurysm development with no elastase-induced mortality compared with control animals (circumference, controls: 2.9 ± 0.2 vs. elastase: 5.5 ± 0.9 mm; P < 0.01). PDT after elastase incubation did not inhibit inflammatory cell infiltration. No significant change in the circumference was observed between elastase incubation and PDT treatment after elastase incubation (circumference, elastase: 5.5 ± 0.9 vs. elastase and PDT: 6.1 ± 0.8 mm; P < 0.01). Despite a PDT-induced resistance to protease digestion, PDT did not reduce aortic dilatation in the elastase-treated rat aorta. These findings suggest that PDT may not be a useful modality to prevent aneurysm growth.
Vascular | 2018
Jan Brunkwall; Carlos Vaquero Puerta; Joerg Heckenkamp; Jose Maria Egaña Barrenechea; Piotr Szopiński; Gerard Mertikian; Sven Seifert; Gerhard Rümenapf; Semih Buz; Afshin Assadian; Payman Majd; Spyridon N. Mylonas; Alvaro Revilla Calavia; Thorsten Theis; Mariano de Blas Bravo; Eliza Pleban; Jasper Schupp; Mirko Esche; Cetin Kocaer; Kornelia Hirsch; Alexander Oberhuber; Jost-Philipp Schäfer
Objectives To study the safety and feasibility of the E-liac Stent Graft System® in patients with aorto/iliac aneurysms. Methods A prospective multicentric European registry of patients receiving the E-liac Stent Graft System® was conducted. Endpoints of the study included the technical success as well as periprocedural events and 30-day endoleaks, reinterventions, internal and external iliac artery patency and mortality. Results Between July 2014 and June 2016, a total of 45 patients (93% men, mean age 72 years, range 53–90 years) were enrolled at 11 sites in four European countries. Five patients received an isolated iliac treatment. Thirty-seven patients were treated with a combination of an abdominal stent graft and a unilateral E-liac and three in combination with bilateral E-liac. All E-liac Stent Grafts (48) were implanted in the intended position and the internal iliac arteries were successfully bridged. Two patients did not receive clinical success, due to endoleak type Ia of the aortic stent graft. At 30-day follow-up, clinical success rate was 96%. Three successful endovascular reinterventions were performed within the 30-day follow-up: one due to a type Ia endoleak in the common iliac artery, one due to type Ia endoleak of the aortic stent graft, and one due to bilateral lower limb claudication provoked by stent graft limb stenosis. At 30-day, a 100% survival rate and complete absence of pelvic or buttock ischemia/claudication were reported. Primary patency at 30 days was 100% for the internal iliac artery and 98% for the external iliac artery with an assisted patency of 100% in the latter. Conclusions The high clinical success rate, low rates of device-related reinterventions (2%), and excellent patency rate demonstrate the safety and feasibility of the E-liac Stent Graft System. Long-term results are awaited to state efficacy and durability. Clinical Trials.gov. Identifier no. NCT02209194.
Pathologe | 2002
Hans-Udo Kasper; Volker Dries; Joerg Heckenkamp; H. P. Dienes
ZusammenfassungSkeinoid Fasern (SF) sind 1991 erstmals beschriebene Ablagerungen eines pathologischen Kollagens im interstitiellen Raum, die besonders bei gastrointestinalen Stromatumoren (GIST) vorkommen. Wir berichten über 2 Fälle von GIST des Jejunums mit ausgeprägter Ausbildung von SF, einer bei einem ungewöhnlich jungen Patienten, und demonstrieren den lichtoptischen und ultrastrukturellen Aufbau dieser Fasern. Zudem wird die Bedeutung von SF anhand der neuesten Literatur diskutiert.AbstractSkeinoid fibers are interstitial collections of a pathological collagen, most often seen in gastrointestinal stromal tumors. They were first described in 1991. We report two cases of intestinal stromal tumors, one in an exceptionally young patient with excessive skeinoid fiber deposition. The microscopic as well as the ultrastructural findings of skeinoid fibers are demonstrated and their role is discussed considering the newest literature.
Annals of Vascular Surgery | 2007
Thomas Luebke; Joerg Heckenkamp; Michael Gawenda; K.T.E. Beckurts; K. Lackner; Jan Brunkwall
Annals of Vascular Surgery | 2007
M. Aleksic; Joerg Heckenkamp; Viktor Reichert; Michael Gawenda; Jan Brunkwall
Annales De Chirurgie Vasculaire | 2008
M. Aleksic; Thomas Luebke; Joerg Heckenkamp; Michael Gawenda; Viktor Reichert; Jan Brunkwall
Annales De Chirurgie Vasculaire | 2008
M. Aleksic; Thomas Luebke; Joerg Heckenkamp; Michael Gawenda; Viktor Reichert; Jan Brunkwall